Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CCR5 | P51681 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24654283 | 0.92 | MAPT (0.44) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL24654435 | 0.90 | CCR1 (0.41) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL24654293 | 0.87 | CCR1 (0.43) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL24654305 | 0.85 | CRHR1 (0.43) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL23433737 | 0.85 | LMNA (0.39) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL23434501 | 0.85 | LMNA (0.39) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL24654277 | 0.84 | CCR1 (0.43) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL24654297 | 0.84 | CCR1 (0.43) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL23433753 | 0.84 | LMNA (0.38) | MAPTL3MBTL1CCR1RAB9ACCR5 | |
| SCHEMBL26453898 | 0.83 | CCR1 (0.40) | MAPTL3MBTL1CCR1RAB9ACCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137462-A1 | LIGHT EMITTING ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230137462-A1 | LIGHT EMITTING ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20220328767-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220328767-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | CRY1, NFE2L2, LAGE3 | MAPT 3388/4885L3MBTL1 487/4885CCR1 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.